Font Size




Menu Style

  Return to Menu

 ABSTRACT SUBMISSION                                      Closed 16 January 2023     

Abstracts of original research, for both oral and poster presentations, are positively encouraged. 
  • Correlates of protection of current influenza vaccines
  • Correlates of protection for next generation/ universal influenza vaccines
  • Immune responses and immunological assays for influenza
  • Regulatory challenges for next generation of influenza vaccines
  • Correlates of protection for SARS-CoV-2 and broadly protective coronavirus vaccines
  • Epidemiology
  PLEASE NOTE    If your abstract is accepted by the review committee,
  there will be no registration fee  

      A limited number of travel awards will be available to young investigators who submit abstracts for presentation at the meeting

Notification of acceptance will be sent by 25 January 2023

Publication: Upon submission of an abstract, the author provides consent to allow ISIRV to publish the abstract in the Programme/Abstract Book, and post on the ISIRV website

Co-Author Approval: Please ensure that all co-authors approve of the abstract submission, publication, and potential presentation

Author Disclosure: All abstract authors are required to disclose any conflict of interest.

Changes to Abstract: You are able to edit your abstract until the submission deadline. Once abstract submission closes, only minor abstract changes (author or institution changes, disclosure, keyword or questionnaire updates) are allowed.

The deadline for minor updates and all withdrawals has been extended to 16 January 2023. Any corrections, withdrawals and/or changes may not be accepted after this date.

 All enquiries to